In-depth guides
Focused explainers unpack the difference between psychedelic familiarity and ibogaine-specific questions, including why confidence built in other settings may not transfer. The experience-fails guide follows that question directly.
Independent information services
Services
Guides, comparisons, and research summaries for people asking why experience with psychedelics does not settle the safety questions around ibogaine.
Safety before hype: Kundry is an independent resource designed to keep uncertainty, evidence, and risk in view.
What these offerings are for
Context before confidence
Kundry organizes difficult questions into plain-language information services. The aim is not to provide treatment or replace professional assessment; it is to help people distinguish investigational interest from established safety or effectiveness. The main ibogaine overview frames that distinction for psychonauts, families, researchers, and policymakers.
Ibogaine is commonly discussed in relation to psychedelic experience, but its risk profile cannot be reduced to familiarity with altered states. The compound’s pharmacology and history are not the same thing as a demonstrated safety margin for any individual.
Information offerings
A calmer way to examine a complicated claim
Safety decision frameworks
Structured reading paths help separate a personal story from questions about evidence, contraindications, monitoring, and uncertainty. The framework is informational, not a screening tool or substitute for medical care.
Comparisons and glossary
Plain-language comparisons clarify terms that can blur together in conversation: research, anecdote, investigational use, risk, and effectiveness. Our independent approach and scope explain how Kundry keeps those distinctions visible.
Research summaries and FAQs
Evidence summaries identify what a study can support, what it cannot settle, and where uncertainty remains. U.S. drug information from the Food and Drug Administration offers useful context for understanding the difference between drugs under study and approved treatments.
Research context
Experience is a story. Evidence answers a different question.
Personal experience can be meaningful without functioning as proof of safety. Kundry’s summaries make room for both: individual accounts may describe what happened, while research methods ask different questions about patterns, limitations, and what remains unknown.
The research landscape is designed to make study design and uncertainty easier to inspect. For people looking for context specific to another audience, the independent material on ibogaine treatment for veterans can help distinguish population-specific claims from general assumptions.
Common questions
What Kundry can and cannot offer
Are these medical services?
No. Kundry provides independent informational guides, comparisons, research summaries, and context. It is not a clinic, medical provider, or licensed treatment center.
Why focus on experienced psychedelic users?
Experience with other substances does not establish safety with ibogaine. The focus is on separating familiarity, confidence, and personal narratives from questions about cardiac risk and limited evidence.
How should research summaries be used?
As a way to understand what has been studied, how strongly a claim is supported, and where questions remain. They do not provide personal medical guidance or a basis for self-assessment.
Start with the questions experience cannot answer.
Use the safety primer to explore why evidence, cardiac risk, and uncertainty deserve attention before confidence takes the lead.
Explore the safety primer